Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene t.

Do you trust this headline?

Based on recent headline ratings, 71% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending negative.


Media Trust Score71%